Medigene AG (MDG1.DE)
EUR 1.08
(-1.64%)
EUR 1.08
(-1.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.03 Million | 31.24 Million | 10.46 Million | 8.74 Million | 10.63 Million | 7.75 Million |
| Cost of Revenue | 1.64 Million | 1.98 Million | 1.36 Million | 1.29 Million | 383 Thousand | 849 Thousand |
| Gross Profit | 4.39 Million | 29.26 Million | 9.1 Million | 7.45 Million | 10.24 Million | 6.9 Million |
| Operating Expenses | 20.54 Million | 37.99 Million | 19.08 Million | 30.79 Million | 30.41 Million | 24.73 Million |
| Selling, General and Administrative Expenses | 4.29 Million | 5.07 Million | 2.94 Million | 4.26 Million | 2.98 Million | 3.18 Million |
| Research and Development Expenses | 11.54 Million | 28.49 Million | 12.79 Million | 22.26 Million | 22.62 Million | 7.21 Million |
| Other Expenses | 4.69 Million | 4.41 Million | 3.35 Million | 4.26 Million | 4.8 Million | 14.15 Million |
| Cost and Expenses | 22.18 Million | 39.97 Million | 20.44 Million | 32.08 Million | 30.79 Million | 25.57 Million |
| Operating Income | -16.14 Million | -8.71 Million | -9.98 Million | -23.33 Million | -20.16 Million | -17.82 Million |
| Interest Expense | 548 Thousand | 659 Thousand | 364 Thousand | 428 Thousand | 450 Thousand | 146 Thousand |
| Income Tax Expense | -415 Thousand | -1.04 Million | -300 Thousand | 472 Thousand | 44 Thousand | 45 Thousand |
| Earnings before Tax | -16.59 Million | -9.37 Million | -10.28 Million | -28.4 Million | -19.91 Million | -17 Million |
| Net Income | -16.17 Million | -8.33 Million | -9.98 Million | -28.87 Million | -19.96 Million | -17.04 Million |
| Earnings Per Share Basic | -0.66 | -0.34 | -0.41 | -1.18 | -0.81 | -0.72 |
| Earnings Per Share Diluted | -0.66 | -0.34 | -0.41 | -1.18 | -0.81 | -0.72 |
| Weighted Average Shares Outstanding | 24.56 Million | 24.56 Million | 24.56 Million | 24.56 Million | 24.56 Million | 23.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.56 Million | 24.56 Million | 24.56 Million | 24.56 Million | 24.56 Million | 23.66 Million |
| Gross Margin | 0.73 | 0.94 | 0.87 | 0.85 | 0.96 | 0.89 |
| EBIT Margin | -2.42 | 0.42 | -0.62 | -2.46 | -1.61 | -1.97 |
| Profit Margin | -2.68 | -0.27 | -0.95 | -3.30 | -1.88 | -2.20 |
| EBITDA | -14.58 Million | 13.11 Million | -6.51 Million | -21.53 Million | -17.09 Million | -19.96 Million |
| Earnings Before Tax Margin | -2.68 | -0.28 | -0.95 | -2.67 | -1.90 | -2.30 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.45 Million | 2.23 Million | 1.48 Million | 6.03 Million | 1.48 Million | 1.55 Million |
| Cost of Revenue | 333 Thousand | 386.5 Thousand | 360.5 Thousand | 3.05 Million | 360.5 Thousand | 444 Thousand |
| Gross Profit | 1.12 Million | 1.85 Million | 1.12 Million | 2.98 Million | 1.12 Million | 1.1 Million |
| Operating Expenses | 5.22 Million | 5.17 Million | 5.36 Million | 19.47 Million | 5.36 Million | 5.22 Million |
| Selling, General and Administrative Expenses | 2.09 Million | 2.03 Million | 2.49 Million | - | 2.49 Million | 2.32 Million |
| Research and Development Expenses | 3.13 Million | 3.14 Million | 3.17 Million | - | 3.17 Million | 2.9 Million |
| Other Expenses | -2000.00 | -3499.00 | - | - | - | - |
| Cost and Expenses | 5.55 Million | 5.55 Million | 5.72 Million | 22.52 Million | 5.72 Million | 5.66 Million |
| Operating Income | -4.09 Million | -3.31 Million | -4.38 Million | -16.48 Million | -4.38 Million | -4.11 Million |
| Interest Expense | - | - | 548 Thousand | 548 Thousand | - | - |
| Income Tax Expense | -351.5 Thousand | -500.00 | 157 Thousand | -415 Thousand | 157 Thousand | -197 Thousand |
| Earnings before Tax | -4.08 Million | -3.36 Million | -4.44 Million | -16.59 Million | -4.44 Million | -4.25 Million |
| Net Income | -4.08 Million | -3.36 Million | -4.6 Million | -16.17 Million | -4.6 Million | -4.05 Million |
| Earnings Per Share Basic | -0.15 | -0.13 | -0.19 | - | -0.19 | -0.17 |
| Earnings Per Share Diluted | -0.15 | -0.13 | -0.19 | - | -0.19 | -0.17 |
| Weighted Average Shares Outstanding | 27.18 Million | 25.87 Million | 24.56 Million | 24.56 Million | 24.56 Million | 24.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.18 Million | 25.87 Million | 24.56 Million | 24.56 Million | 24.56 Million | 24.56 Million |
| Gross Margin | 0.77 | 0.83 | 0.76 | 0.49 | 0.76 | 0.71 |
| EBIT Margin | -2.81 | -1.33 | -2.85 | - | -2.81 | -2.66 |
| Profit Margin | -2.80 | -1.50 | -3.10 | -2.68 | -3.10 | -2.62 |
| EBITDA | -4.09 Million | -2.96 Million | -4.23 Million | - | -4.17 Million | -4.11 Million |
| Earnings Before Tax Margin | -2.81 | -1.48 | -2.95 | -2.73 | -2.95 | -2.66 |
LOBEF
1708
PGPKY
CHME
NIPOF
CBVTF